Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burger

Showing results (31-40 of 1,339) with videos related to

Pageof 134
Sort By:
The Journal of the Tennessee Dental Association|April 1, 1982
Touch your patient with loveP A Burger
Blood|January 9, 2016
Obinutuzumab: the more the merrier?Jan A Burger
Blood|April 12, 2012
BRAF mutation: supporting diversity in HCLJan A Burger
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancerR A Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2019
Going through Changes: Surface IgM Levels during CLL Therapy with IbrutinibJan A Burger
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Targeted Agents for the Frontline Management of Chronic Lymphocytic LeukemiaJan A Burger
American Journal of Obstetrics and Gynecology|April 9, 2008
A new model of ovarian carcinogenesis may influence early detection strategiesRobert A Burger
Expert Opinion on Medical Diagnostics|March 14, 2013
The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLLJan A Burger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Experience with bevacizumab in the management of epithelial ovarian cancerRobert A Burger
Leukemia Research|December 19, 2008
CXCR4 in acute myelogenous leukemia (AML): when too much attraction is bad for youJan A Burger
Pageof 134

Showing results (31-40 of 1,339) with videos related to

Sort By:
Pageof 134
The Journal of the Tennessee Dental Association|April 1, 1982
Touch your patient with loveP A Burger
Blood|January 9, 2016
Obinutuzumab: the more the merrier?Jan A Burger
Blood|April 12, 2012
BRAF mutation: supporting diversity in HCLJan A Burger
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancerR A Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2019
Going through Changes: Surface IgM Levels during CLL Therapy with IbrutinibJan A Burger
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Targeted Agents for the Frontline Management of Chronic Lymphocytic LeukemiaJan A Burger
American Journal of Obstetrics and Gynecology|April 9, 2008
A new model of ovarian carcinogenesis may influence early detection strategiesRobert A Burger
Expert Opinion on Medical Diagnostics|March 14, 2013
The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLLJan A Burger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Experience with bevacizumab in the management of epithelial ovarian cancerRobert A Burger
Leukemia Research|December 19, 2008
CXCR4 in acute myelogenous leukemia (AML): when too much attraction is bad for youJan A Burger
Pageof 134